Stefano Aliberti

Summary

Affiliation: University of Milano-Bicocca
Country: Italy

Publications

  1. doi request reprint The changing microbiologic epidemiology of community-acquired pneumonia
    Stefano Aliberti
    Department of Health Science, University of Milan Bicocca, AO San Gerardo, Milan, Italy
    Postgrad Med 125:31-42. 2013
  2. doi request reprint Hospital admission decision for patients with community-acquired pneumonia
    Stefano Aliberti
    Department of Health Science, University of Milan Bicocca, Clinica Pneumologica, AO San Gerardo, Via Pergolesi 33, Monza, Italy
    Curr Infect Dis Rep 15:167-76. 2013
  3. doi request reprint Clinical stability versus clinical failure in patients with community-acquired pneumonia
    Stefano Aliberti
    Dipartimento di Medicina Clinica e Prevenzione, University of Milan Bicocca, San Gerardo Hospital, Via Pergolesi 33, Monza, Italy
    Semin Respir Crit Care Med 33:284-91. 2012
  4. doi request reprint Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia
    Stefano Aliberti
    Dipartimento di Medicina Clinica e Prevenzione, University of Milan Bicocca, Clinica Pneumologica, AO San Gerardo, Monza, Italy
    Clin Infect Dis 54:470-8. 2012
  5. doi request reprint Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia
    Stefano Aliberti
    Dipartimento Toraco polmonare e Cardio circolatorio, University of Milan, Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, Milan, Italy
    Chest 140:482-8. 2011
  6. doi request reprint Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia
    Stefano Aliberti
    Dipartimento di Medicina Clinica e Prevenzione, University of Milan Bicocca, Clinica Pneumologica, AO San Gerardo, Via Pergolesi 33, 20052 Monza
    Respir Med 105:1732-8. 2011
  7. doi request reprint Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective
    Stefano Aliberti
    Department of Health Science, University of Milan Bicocca, Clinica Pneumologica, AO San Gerardo, Monza, Italy
    Thorax 68:997-9. 2013
  8. pmc Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection
    Roberto Cosentini
    Emergency Medicine Department, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Gruppo NIV Policlinico, Milan, Italy
    Respir Res 9:48. 2008
  9. doi request reprint Criteria for clinical stability in hospitalised patients with community-acquired pneumonia
    Stefano Aliberti
    Dept of Health Science, University of Milan Bicocca, AO San Gerardo, Monza, Italy
    Eur Respir J 42:742-9. 2013
  10. pmc Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis
    Stefano Aliberti
    Department of Pathophysiology and Transplantation, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, University of Milan, Via F, Sforza 35, Milan, Italy
    Respir Res 15:27. 2014

Collaborators

Detail Information

Publications29

  1. doi request reprint The changing microbiologic epidemiology of community-acquired pneumonia
    Stefano Aliberti
    Department of Health Science, University of Milan Bicocca, AO San Gerardo, Milan, Italy
    Postgrad Med 125:31-42. 2013
    ..Understanding a patient's risk for drug-resistant pathogens will allow the physician to choose an appropriate empiric treatment regimen to optimize clinical outcomes. ..
  2. doi request reprint Hospital admission decision for patients with community-acquired pneumonia
    Stefano Aliberti
    Department of Health Science, University of Milan Bicocca, Clinica Pneumologica, AO San Gerardo, Via Pergolesi 33, Monza, Italy
    Curr Infect Dis Rep 15:167-76. 2013
    ..In all the other cases, physician's choice to admit CAP patients should be validated against at least one objective tool of risk assessment, with a clear understanding of each score's limitations...
  3. doi request reprint Clinical stability versus clinical failure in patients with community-acquired pneumonia
    Stefano Aliberti
    Dipartimento di Medicina Clinica e Prevenzione, University of Milan Bicocca, San Gerardo Hospital, Via Pergolesi 33, Monza, Italy
    Semin Respir Crit Care Med 33:284-91. 2012
    ..Finally, several efforts should be made to define incidence, timing, and risk factors for nonresolving pneumonia that, to date, remains one of the most indeterminate clinical outcomes in patients with CAP...
  4. doi request reprint Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia
    Stefano Aliberti
    Dipartimento di Medicina Clinica e Prevenzione, University of Milan Bicocca, Clinica Pneumologica, AO San Gerardo, Monza, Italy
    Clin Infect Dis 54:470-8. 2012
    ..Our evaluation was based on actual infection with a resistant pathogen and clinical outcome during hospitalization...
  5. doi request reprint Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia
    Stefano Aliberti
    Dipartimento Toraco polmonare e Cardio circolatorio, University of Milan, Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, Milan, Italy
    Chest 140:482-8. 2011
    ..The objective of this study was to assess the association between TCS and outcomes after discharge in hospitalized patients with CAP...
  6. doi request reprint Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia
    Stefano Aliberti
    Dipartimento di Medicina Clinica e Prevenzione, University of Milan Bicocca, Clinica Pneumologica, AO San Gerardo, Via Pergolesi 33, 20052 Monza
    Respir Med 105:1732-8. 2011
    ..The aim of this study was to evaluate reasons for hospitalization of CAP patients with CURB-65 score of 0 and 1...
  7. doi request reprint Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective
    Stefano Aliberti
    Department of Health Science, University of Milan Bicocca, Clinica Pneumologica, AO San Gerardo, Monza, Italy
    Thorax 68:997-9. 2013
    ..The aim of the study was to validate both Aliberti and Shorr scores in predicting MDR pneumonia, comparing them with healthcare associated pneumonia (HCAP) classification...
  8. pmc Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection
    Roberto Cosentini
    Emergency Medicine Department, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Gruppo NIV Policlinico, Milan, Italy
    Respir Res 9:48. 2008
    ..Chlamydophila pneumoniae and Mycoplasma pneumoniae are associated with acute exacerbation of bronchial asthma (AEBA). The aim of this study was to evaluate the correlation between these acute bacterial infections and the severity of AEBA...
  9. doi request reprint Criteria for clinical stability in hospitalised patients with community-acquired pneumonia
    Stefano Aliberti
    Dept of Health Science, University of Milan Bicocca, AO San Gerardo, Monza, Italy
    Eur Respir J 42:742-9. 2013
    ..714 for ATS/IDSA 2007 criteria (p = 0.645). ATS 2001 and ATS/IDSA 2007 criteria for clinical stability in hospitalised patients with CAP are clinically equivalent and both can be used in clinical practice as well as in clinical research. ..
  10. pmc Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis
    Stefano Aliberti
    Department of Pathophysiology and Transplantation, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, University of Milan, Via F, Sforza 35, Milan, Italy
    Respir Res 15:27. 2014
    ..The aim of the study was to evaluate prevalence, characteristics, risk factors and impact on mortality of hospitalized patients with CAP according to the presence of ARF and SS on admission...
  11. doi request reprint Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy
    Francesco Blasi
    Dipartimento Toraco polmonare e Cardio circolatorio, University of Milan, IRCCS Fondazione Po Ma Re, Milan, Italy
    Pulm Pharmacol Ther 23:200-7. 2010
    ..Long-term azithromycin treatment seems to be safe and effective in severe COPD outpatients with tracheostomy in reducing exacerbations, hospitalizations, as well as in improving quality of life...
  12. pmc Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis
    Francesco Blasi
    Institute of Respiratory Diseases, University of Milan, Fondazione IRCCS Policlinico Mangiagalli Regina Elena, Milano, Italy
    Int J Chron Obstruct Pulmon Dis 2:27-31. 2007
    ..This review discusses the most recent data on the new fluoroquinolone prulifloxacin and critically analyses its activity and safety in the management of AECB...
  13. pmc Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure
    Stefano Aliberti
    Dipartimento Toraco polmonare e Cardio circolatorio, University of Milan, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, Via F, Sforza 35, 20122 Milan, Italy
    Crit Care 14:R196. 2010
    ..The objective of the present study was to investigate the impact of acidemia on admission on outcomes of ACPE patients treated with CPAP...
  14. doi request reprint Antibiotics as immunomodulant agents in COPD
    Francesco Blasi
    Respiratory Medicine Section, Dipartimento Toraco Polmonare e Cardiocircolatorio, University of Milan, IRCCS Fondazione Cà Granda Ospedale Maggiore, Milan, Italy
    Curr Opin Pharmacol 12:293-9. 2012
    ..New macrolide derivatives devoid of antibacterial activity have been synthetized. This review analyses the relevance of immunomodulatory and anti-inflammatory effects of antibiotics in the management of COPD...
  15. doi request reprint Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia
    Stefano Aliberti
    Institute of Respiratory Diseases, University of Milan, Milan, Italy
    Chest 134:955-62. 2008
    ..The objective of this study was to define the incidence, etiology, timing, and risk factors associated with clinical failures related to CAP vs those unrelated to CAP...
  16. doi request reprint Bronchiectasis: an update
    Maria Pappalettera
    Dipartimento Toraco Polmonare e Cardiovascolare, University of Milan, Istituti di Ricovero e Cura a Carattere Scientifico Fondazione PoMaRe, Milan, Italy
    Clin Respir J 3:126-34. 2009
    ..Bronchiectasis is defined as an abnormal and irreversible dilatation of the bronchi, often associated with chronic productive cough, airway obstruction, and recurrent infections...
  17. doi request reprint The role of biomarkers in low respiratory tract infections
    Francesco Blasi
    Dipartimento Toraco polmonare e Cardio circolatorio, University of Milan, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, Via F Sforza 35, Milan, Italy
    Eur J Intern Med 23:429-35. 2012
    ....
  18. ncbi request reprint 100 years of respiratory medicine: pneumonia
    Francesco Blasi
    Istituto di Tisiologia e Malattie dell Apparato Respiratorio, University of Milan, Ospedale Maggiore Fondazione IRCCS Policlinico, Mangiagalli e Regina Elena, Via F Sforza 35, Milan 20122, Italy
    Respir Med 101:875-81. 2007
    ..Guidelines have been issued by international and national scientific societies in order to spread the scientific knowledge on this important disease and to improve its management...
  19. pmc Clinical applications of azithromycin microspheres in respiratory tract infections
    Francesco Blasi
    Institute of Respiratory Diseases, University of Milan, IRCCS Fondazione Policlinico Mangiagalli Regina Elena Milano, Italy
    Int J Nanomedicine 2:551-9. 2007
    ..A further advantage of single-dose therapy is the potential for use as directly-observed therapy, which may be useful in specific clinical conditions...
  20. pmc Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice
    Francesco Blasi
    Institute of Respiratory Diseases, University of Milan, IRCCS Ospedale Maggiore Fondazione Policlinico Mangiagalli Regina Elena, Milano, Italy
    Respir Res 8:83. 2007
    ..pneumoniae is involved in the initiation and promotion of asthma and chronic obstructive pulmonary diseases (COPD). Surprisingly, the effect of C. pneumoniae on airway function has never been investigated...
  21. ncbi request reprint Chlamydia pneumoniae and acute aortic syndrome: a call for a multi-institutional study
    Eduardo Bossone
    Institute of Respiratory Disease, University of Milan, IRCCS Fondazione Policlinico Mangiagalli Regina Elena, Milano, Italy
    Monaldi Arch Chest Dis 70:68-70. 2008
    ..pneumoniae and acute aortic dissection. Well-designed large prospective studies are needed in order to clarify the pathophysiologic role of CP infection in acute and chronic aortic disease...
  22. ncbi request reprint Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia
    Anna Maria Brambilla
    Emergency Medicine Department, IRCCS Fondazione Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy
    Intensive Care Med 40:942-9. 2014
    ..The aim of this study was to compare CPAP vs. oxygen therapy to reduce the risk of meeting criteria for endotracheal intubation (ETI)...
  23. ncbi request reprint Highlights on the appropriate use of fluoroquinolones in respiratory tract infections
    Francesco Blasi
    Institute of Respiratory Diseases, University of Milan, Fondazione IRCCS Policlinico Mangiagalli Regina Elena, Via F Sforza 35, 20122 Milan, Italy
    Pulm Pharmacol Ther 19:11-9. 2006
    ..This review discusses the most recent data on the bacteriological and clinical activity of the new fluoroquinolones and critically analyses the risks of a potential overuse of this valuable new class of drugs...
  24. doi request reprint Mortality in acute cardiogenic pulmonary edema treated with continuous positive airway pressure
    Roberto Cosentini
    Emergency Medicine Department, Ospedale Maggiore, IRCCS Fondazione Policlinico Mangiagalli Regina Elena, Via F Sforza 35, 20122, Milan, Italy
    Intensive Care Med 35:299-305. 2009
    ..To investigate mortality in acute cardiogenic pulmonary edema (ACPE) patients treated with continuous positive airway pressure (CPAP) and to identify clinical and laboratory characteristics associated with mortality...
  25. ncbi request reprint The management of community-acquired pneumonia in the elderly
    Paola Faverio
    Department of Health Science, University of Milan Bicocca, Clinica Pneumologica, AO San Gerardo, Via Pergolesi 33, Monza, Italy University of Texas Health Science Center at San Antonio, TX, USA
    Eur J Intern Med 25:312-9. 2014
    ..Finally, we review the main outcomes, preventive and supportive measures to be considered in elderly patients with pneumonia. ..
  26. ncbi request reprint Geriatric multidimensional assessment for elderly patients with acute respiratory diseases
    Giuseppe Bellelli
    Department of Health Sciences, University of Milano Bicocca, Milan, Italy Geriatric Clinic, San Gerardo Hospital, Monza, Italy Electronic address
    Eur J Intern Med 25:304-11. 2014
    ..Finally we describe the evidence on the comprehensive geriatric assessment, i.e., the method that is required to identify and understand the ultimate needs of elderly complex subjects. ..
  27. ncbi request reprint Strategic targets of essential host-pathogen interactions
    Francesco Blasi
    Institute of Respiratory Diseases, University of Milan, IRCCS Ospedale Maggiore Milano, Milano, Italy
    Respiration 72:9-25. 2005
    ....
  28. ncbi request reprint Cardiac diseases complicating community-acquired pneumonia
    Stefano Aliberti
    aDepartment of Health Science, University of Milan Bicocca, Respiratory Dept, AO San Gerardo, Monza, Italy bChief, Division of Infectious Diseases and Professor of Medicine, Department of Medicine, University of Louisville, Louisville, Kentucky, USA
    Curr Opin Infect Dis 27:295-301. 2014
    ..The aim is to evaluate basic mechanisms, prevalence, risk factors, outcomes, and potential treatments of cardiovascular events (CVEs) in patients with community-acquired pneumonia (CAP)...
  29. pmc The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients
    Francesco Blasi
    Department of Pathophysiology and Transplantation, Universita degli Studi di Milano, IRCCS Fondazione Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy
    PLoS ONE 9:e101228. 2014
    ..This study assesses the burden of COPD in the general population, and the influence of exacerbations (E-COPD) on disease progression and costs...